Tirzepatide (LY3298176) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for type 2 diabetes research. This white powder formulation demonstrates superior efficacy in glucose control and weight management compared to selective GLP-1 agonists.
Our tirzepatide near me offers researchers a high-purity compound with 99%+ pharmaceutical grade quality. The product shows greater affinity for GIP receptors while maintaining significant GLP-1 receptor activity, making it particularly valuable for metabolic studies.
Available in flexible packaging options to meet various research needs. We offer customization of vial sizes (2mg, 5mg, 10mg, 15mg, 20mg, 30mg, 50mg) with optional private labeling services for qualified research institutions.
For researchers seeking tirzepatide near me, our manufacturing facility produces consistent, high-quality batches with comprehensive analytical documentation. All materials are strictly for research use only and not intended for human consumption.